Cingulate Inc. Diluted Shares Outstanding (Weighted Average)
Cingulate Inc. (CING) reported Diluted Shares Outstanding (Weighted Average) of 13.19 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-08-13
- Cingulate Inc. weighted average number of shares outstanding, diluted for the quarter ending 2026-06-30 was 13.19M shares, a 200.40% increase year-over-year.
- Cingulate Inc. weighted average number of shares outstanding, diluted for the quarter ending 2026-03-31 was 9.78M shares, a 168.11% increase year-over-year.
- Cingulate Inc. weighted average number of shares outstanding, diluted for the quarter ending 2025-12-31 was 6.73M shares, a 104.63% increase year-over-year.
- Cingulate Inc. weighted average number of shares outstanding, diluted for the quarter ending 2025-09-30 was 5.43M shares, a 207.48% increase year-over-year.
- Cingulate Inc. weighted average number of shares outstanding, diluted for fiscal 2025 was 5.06M shares, a 231.54% increase from fiscal 2024.
- Cingulate Inc. weighted average number of shares outstanding, diluted for fiscal 2024 was 1.52M shares, a 1921.34% increase from fiscal 2023.
- Cingulate Inc. weighted average number of shares outstanding, diluted for fiscal 2023 was 75.44K shares, a 87.48% decline from fiscal 2022.
- Cingulate Inc. weighted average number of shares outstanding, diluted for fiscal 2022 was 602.34K shares.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 6 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 9 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 12 month | Weighted Average Number of Shares Outstanding, Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 13.19M shares 10-Q · filed 2026-08-13 | 11.48M shares 10-Q · filed 2026-08-13 | 9.90M shares derived: average of 3 quarters · filed 2026-08-13 | 8.78M shares derived: average of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | 9.78M shares 10-Q · filed 2026-05-14 | 8.26M shares derived: average of 2 quarters · filed 2026-05-14 | 7.31M shares derived: average of 3 quarters · filed 2026-05-14 | 6.58M shares derived: average of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | 6.73M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | 6.08M shares derived: average of 2 quarters · filed 2026-03-18 | 5.52M shares derived: average of 3 quarters · filed 2026-08-13 | 5.06M shares 10-K · filed 2026-03-18 | ||||
| 2025-09-30 | 5.43M shares 10-Q · filed 2025-11-13 | 4.91M shares derived: average of 2 quarters · filed 2026-08-13 | 4.50M shares 10-Q · filed 2025-11-13 | 4.19M shares derived: average of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | 4.39M shares 10-Q · filed 2026-08-13 | 4.02M shares 10-Q · filed 2026-08-13 | 3.78M shares derived: average of 3 quarters · filed 2026-08-13 | 3.27M shares derived: average of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | 3.65M shares 10-Q · filed 2026-05-14 | 3.47M shares derived: average of 2 quarters · filed 2026-05-14 | 2.90M shares derived: average of 3 quarters · filed 2026-05-14 | 2.32M shares derived: average of 4 quarters · filed 2026-05-14 | ||||
| 2024-12-31 | 3.29M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | 2.53M shares derived: average of 2 quarters · filed 2026-03-18 | 1.88M shares derived: average of 3 quarters · filed 2026-03-18 | 1.52M shares 10-K · filed 2026-03-18 | ||||
| 2024-09-30 | 1.77M shares 10-Q · filed 2025-11-13 | 1.18M shares derived: average of 2 quarters · filed 2025-11-13 | 936.12K shares 10-Q · filed 2025-11-13 | 721.99K shares derived: average of 4 quarters · filed 2025-11-13 | ||||
| 2024-06-30 | 586.31K shares 10-Q · filed 2025-08-19 | 503.60K shares 10-Q · filed 2025-08-19 | 373.86K shares derived: average of 3 quarters · filed 2025-08-19 | 300.99K shares derived: average of 4 quarters · filed 2025-08-19 | ||||
| 2024-03-31 | 412.13K shares 10-Q · filed 2025-05-08 | 4.95M shares 10-Q · filed 2024-05-08 | 267.63K shares derived: average of 2 quarters · filed 2025-05-08 | 205.88K shares derived: average of 3 quarters · filed 2025-05-08 | 398.05K shares derived: average of 4 quarters · filed 2025-05-08 | |||
| 2023-12-31 | 123.14K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | 102.75K shares derived: average of 2 quarters · filed 2025-03-27 | 393.36K shares derived: average of 3 quarters · filed 2025-03-27 | 75.44K shares 10-K · filed 2025-03-27 | 905.23K shares 10-K · filed 2024-04-01 | |||
| 2023-09-30 | 82.36K shares 10-Q · filed 2024-11-07 | 19.77M shares 10-Q · filed 2023-11-13 | 528.47K shares derived: average of 2 quarters · filed 2024-11-07 | 59.53K shares 10-Q · filed 2024-11-07 | 14.29M shares 10-Q · filed 2023-11-13 | -7.47M shares derived: average of 4 quarters · filed 2024-11-07 | ||
| 2023-06-30 | 974.57K shares 10-Q · filed 2024-08-13 | 11.69M shares 10-Q · filed 2023-08-14 | 958.60K shares 10-Q · filed 2024-08-13 | 11.50M shares 10-Q · filed 2023-08-14 | -9.99M shares derived: average of 3 quarters · filed 2024-08-13 | -4.67M shares derived: average of 4 quarters · filed 2024-08-13 | ||
| 2023-03-31 | 565.47K shares 10-Q · filed 2024-05-08 | -15.48M shares derived: average of 2 quarters · filed 2024-05-08 | -6.55M shares derived: average of 3 quarters · filed 2024-05-08 | -2.08M shares derived: average of 4 quarters · filed 2024-05-08 | ||||
| 2022-12-31 | -31.52M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | -10.10M shares derived: average of 2 quarters · filed 2024-04-01 | -2.97M shares derived: average of 3 quarters · filed 2024-04-01 | 602.34K shares 10-K · filed 2024-04-01 | ||||
| 2022-09-30 | 11.31M shares 10-Q · filed 2023-11-13 | 11.31M shares derived: average of 2 quarters · filed 2023-11-13 | 11.31M shares 10-Q · filed 2023-11-13 | |||||
| 2022-06-30 | 11.31M shares 10-Q · filed 2023-08-14 | 11.31M shares 10-Q · filed 2023-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |